Ocular Therapeutix, Inc.

OCUL · Healthcare

$10.57

Market cap: 2.32B USDDividend yield: —
AdvanceIs it a good moment to buy Ocular Therapeutix, Inc.? Ask Copenvest AIGet an Advance AI take on timing, risk, and what tracked investors are doing.Ask Copenvest AI

Loading chart…

News

Latest headlines for this stock

Insider MonkeySep 3, 2026, 11:06 AM

Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising Costs

GlobeNewswireSep 1, 2026, 11:00 AM

Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences

StockStorySep 1, 2026, 10:10 AM

1 Cash-Heavy Stock on Our Buy List and 2 Facing Challenges

Simply Wall St.Aug 22, 2026, 6:10 AM

Ocular Therapeutix (OCUL) Could Be 59% Undervalued Following Earnings Beat And AXPAXLI Progress

StockStoryAug 21, 2026, 7:47 PM

Pharmaceuticals Stocks Q2 Highlights: Ocular Therapeutix (NASDAQ:OCUL)